Viking Therapeutics Inc (NASDAQ: VKTX): Do Not Miss The Gain Train
Viking Therapeutics Inc (VKTX) concluded trading on Thursday at a closing price of $28.89, with 8.49 million shares of worth about $245.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 98.01% during that period and on Thursday the price saw a gain of […]
Following The Money: Institution’s Growing Stake In Viking Therapeutics Inc (NASDAQ: VKTX)
Viking Therapeutics Inc (VKTX) concluded trading on Thursday at a closing price of $23.95, with 3.35 million shares of worth about $80.22 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 72.18% during that period and on Thursday, February 01 price saw a loss […]
Viking Therapeutics Inc (NASDAQ: VKTX): Hunting Genuine Value In Market Debris
Fidelity Management & Research Co recently announced the acquisition of new stake in Viking Therapeutics Inc (NASDAQ:VKTX). The institutional investor has increased its shareholding in the Healthcare company by 0.19% to 14.94 million shares with purchase of 28523.0 shares. This fresh investment now brings its stake to 14.94% valued currently at $182.58 million. In addition, […]
Viking Therapeutics Inc (NASDAQ: VKTX): Analyst View Points To Future Growth
Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $182.58 million. […]
Viking Therapeutics Inc (NASDAQ: VKTX) – Not A Clear Buying Opportunity?
Fidelity Management & Research Co has recently announced that it has increased stake in Viking Therapeutics Inc (NASDAQ:VKTX) by 0.19%. After grabbing 14.94 million shares, the institutional investor is now in possession of 28523.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.94% having worth around $146.57 million. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Viking Therapeutics Inc (NASDAQ: VKTX)
Fidelity Management & Research Co recently announced the acquisition of new stake in Viking Therapeutics Inc (NASDAQ:VKTX). The institutional investor has increased its shareholding in the Healthcare company by 0.19% to 14.94 million shares with purchase of 28523.0 shares. This fresh investment now brings its stake to 14.94% valued currently at $146.57 million. In addition, […]
